• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长春新碱在体内可激活慢性淋巴细胞白血病中的c-Jun氨基末端激酶。

Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo.

作者信息

Bates Darcy J P, Lewis Lionel D, Eastman Alan, Danilov Alexey V

机构信息

Department of Medicine.

Norris Cotton Cancer Center; Geisel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH, 03756, USA.

出版信息

Br J Clin Pharmacol. 2015 Sep;80(3):493-501. doi: 10.1111/bcp.12624. Epub 2015 May 19.

DOI:10.1111/bcp.12624
PMID:25753324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4574834/
Abstract

AIMS

The authors' aim was to conduct a proof-of-principle study to test whether c-Jun N-terminal kinase (JNK) phosphorylation and Noxa induction occur in peripheral blood chronic lymphocytic leukaemia (CLL) cells in patients receiving a vincristine infusion.

METHODS

Patients with CLL received 2 mg vincristine by a 5-min intravenous infusion. Blood samples were collected at baseline and up to 6 h after the vincristine infusion, and assayed for JNK activation, Noxa induction and vincristine plasma concentrations.

RESULTS

Ex vivo treated peripheral CLL cells activated JNK in response to 10-100 nM vincristine in 6 h. Noxa protein expression, while variable, was also observed over this time frame. In CLL patients, vincristine infusion led to rapid (<1 h) JNK phosphorylation in peripheral blood CLL cells which was sustained for at least 4-6 h after the vincristine infusion. Noxa protein expression was not observed in response to vincristine infusion.

CONCLUSIONS

This study confirmed that vincristine can activate JNK but not induce Noxa in CLL cells in vivo. The results suggest that novel JNK-dependent drug combinations with vincristine warrant further investigation.

摘要

目的

作者旨在进行一项原理验证研究,以测试接受长春新碱输注的慢性淋巴细胞白血病(CLL)患者外周血CLL细胞中是否发生c-Jun氨基末端激酶(JNK)磷酸化和Noxa诱导。

方法

CLL患者通过5分钟静脉输注接受2mg长春新碱。在基线时以及长春新碱输注后长达6小时采集血样,检测JNK激活、Noxa诱导和长春新碱血浆浓度。

结果

体外处理的外周CLL细胞在6小时内对10-100 nM长春新碱产生反应,激活JNK。在这个时间范围内也观察到Noxa蛋白表达,尽管存在差异。在CLL患者中,长春新碱输注导致外周血CLL细胞中JNK快速(<1小时)磷酸化,在长春新碱输注后至少持续4-6小时。未观察到长春新碱输注后Noxa蛋白表达。

结论

本研究证实长春新碱可在体内激活CLL细胞中的JNK,但不诱导Noxa。结果表明,与长春新碱联合使用的新型JNK依赖性药物组合值得进一步研究。

相似文献

1
Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo.长春新碱在体内可激活慢性淋巴细胞白血病中的c-Jun氨基末端激酶。
Br J Clin Pharmacol. 2015 Sep;80(3):493-501. doi: 10.1111/bcp.12624. Epub 2015 May 19.
2
Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells.Jun氨基末端激酶的激活是长春新碱诱导黑色素瘤细胞凋亡的一种介质。
Anticancer Drugs. 2008 Feb;19(2):189-200. doi: 10.1097/CAD.0b013e3282f3138a.
3
Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.细胞周期蛋白依赖性激酶抑制剂P1446A以JNK/p38丝裂原活化蛋白激酶依赖的方式诱导慢性淋巴细胞白血病B细胞凋亡。
PLoS One. 2015 Nov 25;10(11):e0143685. doi: 10.1371/journal.pone.0143685. eCollection 2015.
4
The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stresses.c-Jun氨基末端激酶激活及随后的Bcl-2磷酸化对人B细胞凋亡诱导的作用取决于特定应激的作用方式。
Toxicol Appl Pharmacol. 2008 Apr 1;228(1):93-104. doi: 10.1016/j.taap.2007.11.032. Epub 2007 Dec 14.
5
Aspirin induces apoptosis in human leukemia cells independently of NF-kappaB and MAPKs through alteration of the Mcl-1/Noxa balance.阿司匹林通过改变 Mcl-1/Noxa 平衡,独立于 NF-κB 和 MAPKs 诱导人白血病细胞凋亡。
Apoptosis. 2010 Feb;15(2):219-29. doi: 10.1007/s10495-009-0424-9.
6
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.通过B细胞受体的持续信号传导诱导Mcl-1并促进慢性淋巴细胞白血病B细胞的存活。
Blood. 2005 Jun 15;105(12):4820-7. doi: 10.1182/blood-2004-07-2669. Epub 2005 Feb 22.
7
Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.天冬氨酸-谷氨酸-缬氨酸-天冬氨酸(Asp-Glu-Val-Asp)导向的、半胱天冬酶介导的丝裂原活化蛋白激酶激酶1切割、c-Jun氨基末端激酶激活以及随后Bcl-2磷酸化参与紫杉醇诱导HL-60细胞凋亡的过程。
Mol Pharmacol. 2001 Feb;59(2):254-62. doi: 10.1124/mol.59.2.254.
8
Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.三氧化二砷诱导 B 慢性淋巴细胞白血病细胞凋亡涉及通过 c-jun-NH2 末端激酶激活和 PTEN 上调抑制磷酸肌醇 3-激酶/Akt 存活途径。
Clin Cancer Res. 2010 Sep 1;16(17):4382-91. doi: 10.1158/1078-0432.CCR-10-0072. Epub 2010 Jun 9.
9
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105.微管破坏剂BNC105对慢性淋巴细胞白血病细胞凋亡的快速诱导作用
Cancer Biol Ther. 2016;17(3):291-9. doi: 10.1080/15384047.2016.1139245. Epub 2016 Jan 30.
10
Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.长春碱能迅速诱导 NOXA 的表达,并使原发性慢性淋巴细胞白血病细胞对 ABT-737 产生急性敏感性。
Mol Cancer Ther. 2013 Aug;12(8):1504-14. doi: 10.1158/1535-7163.MCT-12-1197. Epub 2013 May 30.

引用本文的文献

1
Sericin-coated MnO@CeO nanocatalysts enable pH-responsive and synergistic vincristine delivery for lung cancer therapy.丝胶蛋白包覆的MnO@CeO纳米催化剂实现了用于肺癌治疗的pH响应性和协同长春新碱递送。
Sci Rep. 2025 Jul 11;15(1):25048. doi: 10.1038/s41598-025-10182-z.
2
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.BNC105P与依鲁替尼用于复发/难治性慢性淋巴细胞白血病患者的I期试验。
EJHaem. 2022 Aug 11;3(4):1445-1448. doi: 10.1002/jha2.543. eCollection 2022 Nov.
3
Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction.醋丁洛尔,一种心脏选择性β受体阻滞剂,通过抑制JNK-JIP1相互作用促进糖尿病模型细胞对葡萄糖的摄取。
Biomol Ther (Seoul). 2018 Sep 1;26(5):458-463. doi: 10.4062/biomolther.2017.123.
4
Essential oil from Siegesbeckia pubescens induces apoptosis through the mitochondrial pathway in human HepG2 cells.毛梗豨莶精油通过线粒体途径诱导人肝癌HepG2细胞凋亡。
J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):87-92. doi: 10.1007/s11596-017-1699-7. Epub 2017 Feb 22.
5
Polyphyllin I inhibits the growth of ovarian cancer cells in nude mice.重楼皂苷 I 抑制裸鼠卵巢癌细胞的生长。
Oncol Lett. 2016 Dec;12(6):4969-4974. doi: 10.3892/ol.2016.5348. Epub 2016 Nov 3.
6
Microtubule destabilising agents: far more than just antimitotic anticancer drugs.微管解聚剂:远不止是抗有丝分裂抗癌药物。
Br J Clin Pharmacol. 2017 Feb;83(2):255-268. doi: 10.1111/bcp.13126. Epub 2016 Oct 18.
7
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105.微管破坏剂BNC105对慢性淋巴细胞白血病细胞凋亡的快速诱导作用
Cancer Biol Ther. 2016;17(3):291-9. doi: 10.1080/15384047.2016.1139245. Epub 2016 Jan 30.
8
Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.细胞周期蛋白依赖性激酶抑制剂P1446A以JNK/p38丝裂原活化蛋白激酶依赖的方式诱导慢性淋巴细胞白血病B细胞凋亡。
PLoS One. 2015 Nov 25;10(11):e0143685. doi: 10.1371/journal.pone.0143685. eCollection 2015.

本文引用的文献

1
The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.Nedd8激活酶抑制剂MLN4924可抑制微环境驱动的NF-κB激活,并诱导慢性淋巴细胞白血病B细胞凋亡。
Clin Cancer Res. 2014 Mar 15;20(6):1576-89. doi: 10.1158/1078-0432.CCR-13-0987.
2
Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center.单中心靶向治疗对复发的del(17p13.1)核型慢性淋巴细胞白血病患者预后的影响
Leukemia. 2014 Jun;28(6):1365-8. doi: 10.1038/leu.2014.42. Epub 2014 Jan 23.
3
Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism.地西他滨(SCH727965)通过一种依赖细胞周期蛋白依赖性激酶1(CDK1)和5的机制抑制未折叠蛋白反应。
Mol Cancer Ther. 2014 Mar;13(3):662-74. doi: 10.1158/1535-7163.MCT-13-0714. Epub 2013 Dec 20.
4
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias.新型细胞周期蛋白依赖性激酶抑制剂达昔替尼(SCH727965)在急性白血病中的临床和实验室研究。
Cancer Chemother Pharmacol. 2013 Oct;72(4):897-908. doi: 10.1007/s00280-013-2249-z. Epub 2013 Aug 15.
5
Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.长春碱能迅速诱导 NOXA 的表达,并使原发性慢性淋巴细胞白血病细胞对 ABT-737 产生急性敏感性。
Mol Cancer Ther. 2013 Aug;12(8):1504-14. doi: 10.1158/1535-7163.MCT-12-1197. Epub 2013 May 30.
6
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signaling.地那西布(一种细胞周期蛋白依赖性激酶抑制剂)的抗黑色素瘤活性依赖于 p53 信号通路。
PLoS One. 2013;8(3):e59588. doi: 10.1371/journal.pone.0059588. Epub 2013 Mar 18.
7
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.ABT-199,一种强效和选择性的 BCL-2 抑制剂,在发挥抗肿瘤活性的同时不影响血小板。
Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6.
8
NIH Image to ImageJ: 25 years of image analysis.NIH 图像到 ImageJ:25 年的图像分析。
Nat Methods. 2012 Jul;9(7):671-5. doi: 10.1038/nmeth.2089.
9
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.内质网应激与自噬:细胞周期蛋白依赖性激酶抑制剂 flavopiridol 的作用机制和耐药性新发现。
Blood. 2012 Aug 9;120(6):1262-73. doi: 10.1182/blood-2011-12-400184. Epub 2012 Jun 27.
10
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.慢性淋巴细胞白血病对 BCL2 抑制作用的显著敏感性:navitoclax 治疗复发或难治性疾病患者的 I 期研究结果。
J Clin Oncol. 2012 Feb 10;30(5):488-96. doi: 10.1200/JCO.2011.34.7898. Epub 2011 Dec 19.